• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH PATHROMTIN SL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH PATHROMTIN SL Back to Search Results
Model Number PATHROMTIN SL
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2023
Event Type  malfunction  
Event Description
Falsely elevated activated partial thromboplastin time (aptt) results were obtained on a patient sample using pathromtin sl reagent on two sysmex cs-5100 systems.The first erroneous result was reported and questioned by the physician(s) as the patient previously had a lower aptt result two days prior.The sample was then repeated for aptt on a non-siemens analyzer using a non-siemens reagent, recovering lower.The lower result was reported, as the correct result, to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the falsely elevated aptt results.
 
Manufacturer Narrative
An outside of the united states (ous) customer contacted a siemens customer care center (ccc).Siemens is investigating the issue.
 
Manufacturer Narrative
Siemens filed the initial mdr 9610806-2023-00014 on 06-sep-2023.Additional information (08-sep-2023): siemens further evaluated the incident and determined that there was no reagent issue.Quality controls (qc) recovered in range at the time of the event.A repeatability and comparison study was performed between both sysmex cs-5100 systems for activated partial thromboplastin time (aptt) and the aptt results were comparable on both systems.No further erroneous results have been reported.Preanalytical variables potentially contributed to this event.The investigation findings and investigation conclusion codes in section h6 were updated to reflect the additional information.The reagent is performing according to specifications.No further evaluation of this device is required.Mdrs 9610806-2023-00013 and 9610806-2023-00015 and the associated supplemental reports were also filed for this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PATHROMTIN SL
Type of Device
PATHROMTIN SL
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring- str. 76
marburg D-350 41
GM  D-35041
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
emil-von-behring- str. 76
marburg D-350 41
GM   D-35041
Manufacturer Contact
christopher aebig
511 benedict ave.
tarrytown, NY 10591
9144153450
MDR Report Key17695213
MDR Text Key322812009
Report Number9610806-2023-00014
Device Sequence Number1
Product Code GFO
UDI-Device Identifier00842768007538
UDI-Public00842768007538
Combination Product (y/n)N
Reporter Country CodeSI
PMA/PMN Number
K955450
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 09/29/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPATHROMTIN SL
Device Catalogue Number10446067
Device Lot Number536751A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/08/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-